• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与蛋白脂蛋白肽结合的HLA - A*0301结构:深入了解HLA - A等位基因在多发性硬化易感性中的作用

Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.

作者信息

McMahon Róisín M, Friis Lone, Siebold Christian, Friese Manuel A, Fugger Lars, Jones E Yvonne

机构信息

Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX39DS, England.

出版信息

Acta Crystallogr D Biol Crystallogr. 2011 May;67(Pt 5):447-54. doi: 10.1107/S0907444911007888. Epub 2011 Apr 13.

DOI:10.1107/S0907444911007888
PMID:21543847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3087623/
Abstract

The structure of the human major histocompatability (MHC) class I molecule HLA-A*0301 (HLA-A3) in complex with a nonameric peptide (KLIETYFSK) has been determined by X-ray crystallography to 2.7 Å resolution. HLA-A3 is a predisposing allele for multiple sclerosis (MS), an autoimmune disease of the central nervous system. The KLIETYFSK peptide is a naturally processed epitope of proteolipid protein, a myelin protein and candidate target for immune-mediated myelin destruction in MS. Comparison of the structure of HLA-A3 with that of HLA-A2, an MHC class I molecule which is protective against MS, indicates that both MHC class I molecules present very similar faces for T-cell receptor recognition whilst differing in the specificity of their peptide-binding grooves. These characteristics may underlie the opposing (predisposing versus protective) associations that they exhibit both in humans and in mouse models of MS-like disease. Furthermore, subtle alterations within the peptide-binding groove of HLA-A3 and other A3-like MHC class I molecules, members of the so-called A3 superfamily, may be sufficient to alter their presentation of autoantigen peptides such as KLIETYFSK. This in turn may modulate their contribution to the associated risk of autoimmune disease.

摘要

通过X射线晶体学已确定人类主要组织相容性复合体(MHC)I类分子HLA - A*0301(HLA - A3)与九聚体肽(KLIETYFSK)形成复合物的结构,分辨率达到2.7埃。HLA - A3是多发性硬化症(MS)的一个易感等位基因,MS是一种中枢神经系统的自身免疫性疾病。KLIETYFSK肽是蛋白脂蛋白的天然加工表位,蛋白脂蛋白是一种髓磷脂蛋白,也是MS中免疫介导的髓磷脂破坏的候选靶点。将HLA - A3的结构与HLA - A2(一种对MS有保护作用的MHC I类分子)的结构进行比较,结果表明,这两种MHC I类分子在T细胞受体识别方面呈现出非常相似的表面,而它们的肽结合槽的特异性有所不同。这些特征可能是它们在人类和MS样疾病小鼠模型中表现出相反(易感与保护)关联的基础。此外,HLA - A3和其他A3样MHC I类分子(即所谓A3超家族的成员)的肽结合槽内的细微改变,可能足以改变它们对自身抗原肽(如KLIETYFSK)的呈递。这反过来可能会调节它们对自身免疫性疾病相关风险的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/f3a48e2c4040/d-67-00447-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/fc836cc3327f/d-67-00447-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/8c87827f9a3c/d-67-00447-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/f3a48e2c4040/d-67-00447-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/fc836cc3327f/d-67-00447-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/8c87827f9a3c/d-67-00447-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c89/3087623/f3a48e2c4040/d-67-00447-fig3.jpg

相似文献

1
Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.与蛋白脂蛋白肽结合的HLA - A*0301结构:深入了解HLA - A等位基因在多发性硬化易感性中的作用
Acta Crystallogr D Biol Crystallogr. 2011 May;67(Pt 5):447-54. doi: 10.1107/S0907444911007888. Epub 2011 Apr 13.
2
Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily.HLA - A3超家族中自然多态性的生化及结构影响
Mol Immunol. 2005 Jul;42(11):1331-44. doi: 10.1016/j.molimm.2004.12.017. Epub 2005 Feb 24.
3
HLA-A3 supermotif defined by quantitative structure-activity relationship analysis.通过定量构效关系分析定义的HLA - A3超基序。
Protein Eng. 2003 Jan;16(1):11-8. doi: 10.1093/proeng/gzg005.
4
The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.HLA I类分子的肽结合特异性在很大程度上具有等位基因特异性且互不重叠。
Mol Immunol. 1992 Sep;29(9):1131-40. doi: 10.1016/0161-5890(92)90046-z.
5
A comparative molecular similarity indices (CoMSIA) study of peptide binding to the HLA-A3 superfamily.肽与HLA - A3超家族结合的比较分子相似性指数(CoMSIA)研究。
Bioorg Med Chem. 2003 May 15;11(10):2307-11. doi: 10.1016/s0968-0896(03)00109-3.
6
In silico study of the association of the HLA-A*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of PLP (proteolipid protein), MBP (myelin basic protein) and MOG proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis.通过计算机模拟研究 HLA-A*31:01 等位基因(人类白细胞抗原等位基因 31:01)与 PLP(蛋白脂质蛋白)、MBP(髓鞘碱性蛋白)和 MOG 蛋白(少突胶质细胞髓鞘糖蛋白)的神经抗原表位之间的关联,以研究多发性硬化症的发病机制。
J Biomol Struct Dyn. 2021 Apr;39(7):2526-2542. doi: 10.1080/07391102.2020.1751291. Epub 2020 Apr 13.
7
Class I MHC-peptide interaction: structural and functional aspects.I类主要组织相容性复合体-肽相互作用:结构与功能方面
Behring Inst Mitt. 1994 Jul(94):48-60.
8
Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function.使用改良的半经验评分函数预测肽与 MHC 分子的结合亲和力。
PLoS One. 2011;6(9):e25055. doi: 10.1371/journal.pone.0025055. Epub 2011 Sep 22.
9
Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.与HLA - A3结合的内源性肽具有特定的锚定残基组合,这有助于识别潜在的抗原肽。
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1508-12. doi: 10.1073/pnas.90.4.1508.
10
In-silico design of peptides for inhibition of HLA-A*03-KLIETYFSK complex as a new drug design for treatment of multiples sclerosis disease.基于 HLA-A*03-KLIETYFSK 复合物的抑制肽的计算机设计:多发性硬化症治疗的新药设计。
J Mol Graph Model. 2022 Mar;111:108079. doi: 10.1016/j.jmgm.2021.108079. Epub 2021 Nov 16.

引用本文的文献

1
Broadening alloselectivity of T cell receptors by structure guided engineering.通过结构导向工程拓宽 T 细胞受体的 allo 选择性。
Sci Rep. 2024 Nov 6;14(1):26851. doi: 10.1038/s41598-024-75140-7.
2
Overview of myelin, major myelin lipids, and myelin-associated proteins.髓磷脂、主要髓磷脂脂质及髓磷脂相关蛋白概述
Front Chem. 2023 Feb 21;10:1041961. doi: 10.3389/fchem.2022.1041961. eCollection 2022.
3
Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I Molecules.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
REFMAC5 for the refinement of macromolecular crystal structures.用于大分子晶体结构精修的REFMAC5
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. doi: 10.1107/S0907444911001314. Epub 2011 Mar 18.
3
Molecular replacement with MOLREP.使用MOLREP进行分子置换。
工程化人类蛋白酶体对髓鞘碱性蛋白片段的切割揭示了与 MS 相关的和保护性 HLA Ⅰ类分子的直接肽配体。
Int J Mol Sci. 2023 Jan 20;24(3):2091. doi: 10.3390/ijms24032091.
4
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.突变 PIK3CA 衍生的公共新抗原的免疫原性和治疗靶向。
Nat Med. 2022 May;28(5):946-957. doi: 10.1038/s41591-022-01786-3. Epub 2022 Apr 28.
5
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.外周和肿瘤内新生抗原特异性 TCR 的功能分析,在一名黑色素瘤患者中鉴定。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002754.
6
Peptide mimotopes alter T cell function in cancer and autoimmunity.肽模拟物改变癌症和自身免疫中的 T 细胞功能。
Semin Immunol. 2020 Feb;47:101395. doi: 10.1016/j.smim.2020.101395. Epub 2020 Mar 20.
7
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.一种通过主要组织相容性复合体 I 新抗原呈递靶向突变 β-连环蛋白的工程化抗体片段。
J Biol Chem. 2019 Dec 13;294(50):19322-19334. doi: 10.1074/jbc.RA119.010251. Epub 2019 Nov 5.
8
Perspectives on the Prediction of the PLP's Epitopes involved in Multiple Sclerosis.多发性硬化症中与髓鞘碱性蛋白(PLP)表位预测相关的观点。
Iran J Biotechnol. 2017 Mar;15(1):10-21. doi: 10.15171/ijb.1356.
9
Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests.鉴定用于基于细胞的诊断性检测的推定的 Zika 病毒和登革热病毒 1-4 型独特免疫原性肽。
Sci Rep. 2017 Jul 24;7(1):6218. doi: 10.1038/s41598-017-05980-z.
10
Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.白塞病中免疫芯片平台的基因分析。HLA I类区域相关残基及新易感位点的鉴定。
PLoS One. 2016 Aug 22;11(8):e0161305. doi: 10.1371/journal.pone.0161305. eCollection 2016.
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5. doi: 10.1107/S0907444909042589. Epub 2009 Dec 21.
4
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.
5
Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.人类白细胞抗原I类分子在调节多发性硬化症中自身反应性CD8 + T细胞方面的相反作用。
Nat Med. 2008 Nov;14(11):1227-35. doi: 10.1038/nm.1881. Epub 2008 Oct 26.
6
HLA class I supertypes: a revised and updated classification.HLA I类超型:修订与更新后的分类
BMC Immunol. 2008 Jan 22;9:1. doi: 10.1186/1471-2172-9-1.
7
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide.与严重急性呼吸综合征核衣壳肽结合的HLA-A*1101高分辨率结构。
Acta Crystallogr D Biol Crystallogr. 2005 Aug;61(Pt 8):1031-40. doi: 10.1107/S0907444905013090. Epub 2005 Jul 20.
8
Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily.HLA - A3超家族中自然多态性的生化及结构影响
Mol Immunol. 2005 Jul;42(11):1331-44. doi: 10.1016/j.molimm.2004.12.017. Epub 2005 Feb 24.
9
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization.一种用于建立高通量纳升结晶实验的程序。用于初始筛选、自动存储、成像和优化的结晶工作流程。
Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):651-7. doi: 10.1107/S0907444905007808. Epub 2005 May 26.
10
Immunology of multiple sclerosis.多发性硬化症的免疫学
Annu Rev Immunol. 2005;23:683-747. doi: 10.1146/annurev.immunol.23.021704.115707.